跳至主要内容
临床试验/NL-OMON32253
NL-OMON32253已完成3 期

Clopidogrel for the prevention of late cardiac events in patients with asymptomatic perioperative acute coronary syndrome. - DECREASE VII

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) age above 18 years
  • 2) patients scheduled for major vascular surgery, one of the following
  • - Abdominal aortic aneurysm repair
  • - Aortic stenosis repair
  • - Femoropopliteal bypass surgery, above and below knee
  • 3) asymptomatic troponin T release during or after surgery

排除标准

  • 1) Active bleeding
  • 2) Untreated left main disease
  • 3) Active cardiac condition such as unstable angina pectoris, active CHF, serious cardiac arrhythmias, symptomatic valvular disease, recent < 6 months.
  • 4) Preoperative positive troponin T
  • 5) Inability to take clopidogrel orally
  • 6) Clear indication for long-term clopidogrel use
  • 7) Previous allergy or intolerance to clopidogrel
  • 8) Renal failure requiring dialysis
  • 9) Significant liver disease (i.e. ALAT, ASAT >3x ULN)
  • 10) Cancer with an expected life expectancy < 6 months
  • 11) Anticipated non-adherence to clopidogrel
  • 12) Excessive alcohol use
  • 13) Pregnancy or planning to become pregnant
  • 14) Failure to provide informed consent

研究者

相似试验